Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

EvoHealth Celebrates 100th Install Milestone

Company Introduces New Technology to Healthcare IT Market

profits revenue finance money

US Radiology Specialists plots double-digit growth, fueled by M&A, after ‘extremely challenging’ 2020

The Raleigh, North Carolina-based practice plans to add more than 1,000 positions in the next 12 months, and just recently entered NY state.

Thumbnail

Bipartisan group of 50 US senators supports stopping radiologist Medicare pay cuts

The coalition of lawmakers shared their concerns on Friday in a letter to Senate leaders Mitch McConnell and Charles Schumer. 

Healthcare AI startup raises a fresh $226M, spends $120M to acquire another healthcare AI startup

An Ohio-based healthcare AI company focused on improving fiscal performance for payers as well as providers is buying a like-minded entity with expertise in streamlining prior-authorization processes.  

Thumbnail

Medicare cuts expected to limit access for stroke and aneurysm patients, could cause some practices to close

Specialists also believe that private insurers will follow Medicare's example and reduce their own reimbursement rates.

Cardiologist hired for executive vice president role at Walmart

Cheryl Pegus, MD, is a veteran cardiologist with prior experience at such companies as Aetna, Pfizer and Cambia Health Solutions.

Thumbnail

FTC approves Rad Partners’ blockbuster $885M acquisition of Mednax Radiology Solutions

Standard & Poor’s Global Ratings revealed the news in an update shared Dec. 3. 

Thumbnail

Cigna imaging restrictions will have ‘profoundly negative impact’ on pediatric care, radiologists warn

The Society for Pediatric Radiology is expressing significant concerns around a new payment policy, believing it could lead to patient harm and climbing costs.